IRIS
VECCHIO, GIANCARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.062
AS - Asia 6.348
NA - Nord America 6.153
SA - Sud America 871
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 32.608
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.870
US - Stati Uniti d'America 5.944
SG - Singapore 3.159
RU - Federazione Russa 1.926
CN - Cina 1.095
NL - Olanda 909
VN - Vietnam 810
BR - Brasile 719
HK - Hong Kong 594
FR - Francia 438
DE - Germania 387
SE - Svezia 335
FI - Finlandia 294
UA - Ucraina 221
GB - Regno Unito 175
IE - Irlanda 175
CA - Canada 133
IN - India 132
JP - Giappone 88
BD - Bangladesh 80
IQ - Iraq 66
PL - Polonia 64
ZA - Sudafrica 58
ES - Italia 49
AR - Argentina 46
TR - Turchia 46
MX - Messico 43
AL - Albania 32
EC - Ecuador 32
CH - Svizzera 31
PK - Pakistan 27
ID - Indonesia 23
CI - Costa d'Avorio 20
PH - Filippine 19
TH - Thailandia 19
IL - Israele 18
BG - Bulgaria 17
KR - Corea 17
VE - Venezuela 17
IR - Iran 16
RO - Romania 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
AT - Austria 15
BE - Belgio 14
SA - Arabia Saudita 14
TW - Taiwan 14
UY - Uruguay 13
CL - Cile 12
DZ - Algeria 12
LT - Lituania 12
CO - Colombia 11
GR - Grecia 11
JO - Giordania 11
TN - Tunisia 11
KE - Kenya 10
PY - Paraguay 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
DK - Danimarca 9
MA - Marocco 9
NP - Nepal 9
MY - Malesia 8
PE - Perù 8
OM - Oman 7
PT - Portogallo 7
HU - Ungheria 6
DO - Repubblica Dominicana 5
EG - Egitto 5
EU - Europa 5
KZ - Kazakistan 5
NG - Nigeria 5
RS - Serbia 5
SI - Slovenia 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CR - Costa Rica 4
HR - Croazia 4
JM - Giamaica 4
LK - Sri Lanka 4
MD - Moldavia 4
SM - San Marino 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
LU - Lussemburgo 3
LY - Libia 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
GE - Georgia 2
Totale 32.559
Salva come PNG Salva come JPEG
Città #
Singapore 1.308
Rome 1.004
San Jose 810
Naples 757
Milan 734
Hong Kong 571
Moscow 537
Chandler 464
Ashburn 395
Jacksonville 363
Florence 252
Millbury 244
Beijing 239
Turin 232
Ho Chi Minh City 230
Princeton 224
Bologna 216
Palermo 205
Lauterbourg 199
The Dalles 194
Santa Clara 188
Hanoi 176
Nanjing 176
Bari 155
Los Angeles 142
Wilmington 139
Catania 127
Buffalo 119
Padova 119
Boston 113
Amsterdam 109
Napoli 89
Nanchang 84
Tokyo 75
Pescara 73
Brescia 72
Perugia 71
Houston 68
Kronberg 67
New York 66
Verona 66
Parma 64
Dallas 61
Genoa 60
São Paulo 60
Ottawa 58
Munich 57
Salerno 57
Trieste 56
Cagliari 54
Frankfurt am Main 53
Messina 53
Pisa 50
Haiphong 46
Boardman 44
Redondo Beach 44
Reggio Emilia 43
Modena 42
Falls Church 41
Pavia 40
Venice 40
Kunming 39
Shenyang 37
Monza 35
Norwalk 34
Ann Arbor 33
Orem 33
Treviso 32
Turku 32
Caserta 31
Tianjin 31
Seattle 29
Ancona 28
Baghdad 28
Lucca 28
Bergamo 27
Council Bluffs 27
Da Nang 27
Ferrara 27
Chicago 25
Johannesburg 25
Montreal 25
Reggio Calabria 25
Hebei 24
Jiaxing 24
Stockholm 24
Vicenza 24
Warsaw 24
Brooklyn 23
Changsha 23
Chennai 23
Denver 23
Hefei 23
Toronto 23
Afragola 22
Helsinki 22
London 22
Avellino 21
Hangzhou 21
Taranto 21
Totale 13.540
Salva come PNG Salva come JPEG
Nome #
La cascata delle MAPK come bersaglio terapeutico per i carcinomi della tiroide. 15.120
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer 159
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 151
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 150
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 146
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 144
[On the transport of thyroxine by the serum proteins of the Ammocoete of Petromyzon planeri Bl.] 144
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B 140
Patologia Generale 139
Antitumor pancreatic-type RNases 139
ONYX-015, an E1B gene-defective adenovirus,induces cell death in human anaplastic thyroid carcinoma cell lines. 138
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 136
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer 136
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 132
Nino Salvatore tenth anniversary memorial meeting:thyroid and beyond 132
Transformation of differentiated rat thyroid epithelial cells by viral and cellular oncogenes 130
Human papilloma virus 16E7 oncogene does not cooperate with ret/ptc 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice 129
Different mutations of the RET gene cause different human tumoral diseases. 127
Fissazione degli ormoni tiroidei al micrococcus lysodeikticus 125
A dimeric mutant of human pancreas ribonuclease with selective antitumor action 125
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. 121
Ret-mediated mitogenesis requires Src kinase activity. 120
Molecular mechanisms of RET activation in human cancer 120
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. 118
Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells. 118
H4(D10S170),a gene frequently rearranged with RET in papillary thyroid carcinomas:functional characterization. 116
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. 116
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin 116
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati 116
Polyribosomes from rat thyroid gland 116
Espressione dei genomi virali in cellule infettate da MSV e da MuLV 115
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis 114
Signaling through ras is essential for ret oncogene induced cell differentiation in PC12 cells 114
Onyx-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells 114
TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line 114
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. 114
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS 114
Recent advances in understanding immune phenotypes of thyroid carcinomas: Prognostication and emerging therapies [version 1; referees: 2 approved] 114
Studies of some immunological properties of thyroid iodoproteins 113
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. 111
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. 111
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE 109
[On the extracellular localization of the iodide compartment: distribution of I-131 labelled NaI and of Na22 labelled NaCl in the mouse bearing an ascites tumor (Ehrlich's adenocarcinoma).] 108
RET 107
Post-translational modification by sumoylation and ubiquitinylation of H4 (D10S170), the product of first and most frequently observed RET-fused gene 106
In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors. 104
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma 103
Aspetti strutturali e fuzionali delle iodoproteine tiroidee 102
Effetti di una sostanza ad azione anti-tiroidea,l'1- metil-2 -mercapto-imidazolo(tapazolo) sulla iodazione e la biosintesi delle iodoproteine tiroidee di ratto 102
Seminal ribonuclease inhibits tumor growth and reduces the metastatic potential of Lewis lung carcinoma. 101
[On the fixation of thyroid hormones by the isolated cells of Ehrlich's adenocarcinoma (ascites tumor).] 100
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten murine sarcoma virus. 100
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. 98
On the dissociation of human thyroglobulin by ultraviolet irradiation 98
European Thyroid Association: 2006 in Naples. 97
45th Annual Meeting of the Italian Cancer Society 96
Nino Salvatore's contribution to scientific collaboration between Europe and the US in endocrinology. 96
Different mutations of the RET gene cause different human tumoral diseases. 96
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). 95
Verapamil reverts resistance to drug-induced apoptosis in Ki-ras-transformed cells by altering the cell membrane and the mitochondrial transmembrane potentials. 95
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 94
[ON THE DISTRIBUTION OF 3,5,3'-TRIIODO-L-THYRONINE (T3) AND L-THYROXINE (T4) IN THE TISSUE OF MICE BEARING ASCITES TUMOR (EHRLICH'S ADENOCARCINOMA).] 94
Patologia Generale 94
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells 92
The PTC oncogene is able to dedifferentiate a rat thyroid epithelial cell line in culture 92
Biosynthesis of thyroglobulin: Partial characterization of a labeled 6 S precursor 91
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 91
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 90
RET\PTC activation in human thyroid carcinomas 90
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. 89
Effetti dell'interferone sulll'espressione del genoma dell'FLV nelle cellule eritroleucemiche di Friend 89
Molecular mechanisms of RET activation in human neoplasia 88
Preferential expression of the dbl protooncogene in some tumors of neuroectodermal origin. 88
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC. 88
The Kirsten murine sarcoma virus induces rat thyroid carcinomas in vivo 88
Activation of RET oncogene and thyroid carcinogenesis 88
VII Meeting of molecular oncology 87
Presence of physiologically stimulated RET in adult rat brain: induction of RET expression during nerve regeneration. 87
Molecular mechanisms of RET activation in human cancer. 87
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. 87
PRODUCTION OF TRANSGENIC MICE EXPRESSING THE KI-RAS ONCOGENE UNDER THE CONTROL OF A THYROGLOBULIN PROMOTER 85
Molecular mechanisms of RET activation in human neoplasia. 85
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. 83
Activation of RET as a dominant transforming gene by germline mutatios of MEN2A and MEN2B 82
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. 81
Oncogenes of DNA and RNA tumor viruses and the origin of cellular oncogenes. 81
Virus-specific rna and viral proteins in polyribosomesof cells transformed by the murine sarcoma-leukemia virus:Analysis by molecular hibridation immunoprecipitation and polyacrylamide gel electrophoresis 81
The ETA meets in Sweden 79
27S THYROID IODOPROTEIN. ISOLATION AND PROPERTIES. 79
Identification of a chimeric gene frequently activated in human thyroid papillary carcinomas 79
Epidemiologia dei tumori umani 78
Molecular mechanisms of Ret activation in human neoplasia 77
Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture 77
CHARACTERIZATION OF AN INVERSION ON THE LONG ARM OF CHROMOSOME-10 JUXTAPOSING D10S170 AND RET AND CREATING THE ONCOGENIC SEQUENCE RET PTC 77
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. 77
The cooperation between viral ras genes and different immortalizing genes induces the transformation of rat thyroid epithelial cells 76
Molecular cloning of PTC,a new oncogene found activated in human thyiroid papillary carcinomas and their lymph node metastates 75
Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment. 73
Biosynthesis of thyroid iodoproteins in vivo and in tissue slices. 73
Inhibitory action of transforming growth factor beta on thyroid cells. 73
Totale 25.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.153
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 0 0 0 0 0 214 87
2021/20222.549 109 50 126 112 105 186 193 194 262 182 357 673
2022/20233.984 322 145 155 292 351 380 391 406 400 319 382 441
2023/20244.984 274 323 478 337 371 374 726 527 223 293 581 477
2024/20258.590 720 660 405 383 416 513 1.011 653 797 686 1.693 653
2025/20269.145 1.154 605 947 940 1.664 480 947 621 1.085 470 232 0
Totale 32.778